Tasly Pharmaceutical Group Co., Ltd
SHH: 600535.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jin Yong Cai
- Employees
- 10,958
- Headquarters
- Tianjin, China
- IPO year
- 2002
- Market cap
- CN¥22.3B
- Website
- https://www.tasly.com
Loading 600535…
Loading profile data…Frequently asked questions about 600535
What does Tasly Pharmaceutical Group Co., Ltd (600535.SS) do?
Tasly Pharmaceutical Group Co., Ltd. engages in biological medicine, health, and medical service businesses in China. It offers herbal and chemical medicines, health products, pharmaceutical substances and APIs, herbal extracts, concentrated herbal granules, and tea series products. The company also provides cosmetic series products, including m...
Where does 600535.SS trade?
Tasly Pharmaceutical Group Co., Ltd (600535.SS) trades on the Shanghai Stock Exchange.
What sector is 600535.SS in?
Tasly Pharmaceutical Group Co., Ltd (600535.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tasly Pharmaceutical Group Co., Ltd?
Jin Yong Cai is the chief executive officer of Tasly Pharmaceutical Group Co., Ltd (600535.SS).
Where is Tasly Pharmaceutical Group Co., Ltd headquartered?
Tasly Pharmaceutical Group Co., Ltd is headquartered in China.
Does 600535.SS pay a dividend?
Yes — Tasly Pharmaceutical Group Co., Ltd (600535.SS) paid a trailing twelve-month dividend of CNY 0.48 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600535.SS go public?
Tasly Pharmaceutical Group Co., Ltd (600535.SS) completed its initial public offering in 2002.